Hy. Yu et Rf. Liu, HEPATIC-UPTAKE AND TISSUE DISTRIBUTION OF LIPOSOMES - INFLUENCE OF VESICLE SIZE, Drug development and industrial pharmacy, 20(4), 1994, pp. 557-574
The size-dependent disposition of liposomes in rats was studied. Lipos
omes consisting of phosphatidylcholine, cholesterol, dicetylphospate a
nd alpha-tocopherol in a molar ratio of 4:4:1:1, containing a trace of
[C-14]-labeled cholesterol as a marker of the lipid phase, were prepa
red and sized by extruding through polycarbonate membrane. [H-3]-inuli
n was used as a marker of the aqueous phase. In situ liver perfusion i
n rats showed that hepatic extraction of liposomes was significant for
multilamellar vesicles (MLVs) larger than 0.4 mu m (0.40, 0.82 and 1.
31 mu m) and small unilamellar vesicles (SW), but negligible for 0.25
mu m MLV. Pharmacokinetic analysis after intravenous (i.v.) injection
showed that the area under the plasma elimination curve (AUC) was sign
ificantly higher, but the volume of distribution (Vd) and the eliminat
ion rate constant (ke) were significantly lower for the 0.25 mu m than
for the 1.31 mu m liposomes. Comparing the distribution of 1.36 and 0
.25 mu m MLVs after i.v. injection, the 1.31 mu m MLV showed a signifi
cantly higher concentration in liver and spleen, but lower concentrati
on in plasma and kidney, than the 0.26 mu m in terms of dose percent.
These results suggest that size is one of the important factors affect
ing the fate of liposmes in vivo. There must be a minimun size for eff
ective uptake of liposomes by the reticuloendothelial system. If below
the minimum effective uptake size, the MLV should remain in higher co
ncentration in circulation.